Alison Pickover1, Ari Lowell1, Amit Lazarov1, Andrea Lopez-Yianilos1, Arturo Sanchez-Lacay1, Matthew Ryba1, Sara Such1, Shay Arnon1, Doron Amsalem1, Yuval Neria1, John C Markowitz1. 1. New York State Psychiatric Institute, New York City (Pickover, Lowell, Lopez-Yianilos, Sanchez-Lacay, Ryba, Such, Arnon, Amsalem, Neria, Markowitz); Department of Psychiatry, Columbia University Irving Medical Center, New York City (Pickover, Lowell, Lazarov, Sanchez-Lacay, Amsalem, Neria, Markowitz); School of Psychological Sciences, Tel Aviv University, Tel Aviv, Israel (Lazarov); Department of Psychiatry, Weill-Cornell Medical Center, New York City (Ryba).
Abstract
OBJECTIVE: Military service members and veterans have high rates of posttraumatic stress disorder (PTSD), as do military family members. Exposure-based, cognitive-behavioral approaches have received ample research, but other PTSD therapies require further empirical attention. Interpersonal psychotherapy (IPT) targets affective awareness, life circumstances, and social support. IPT has shown efficacy for civilians with PTSD but awaits rigorous testing among military personnel; only two small military pilot studies and two case reports have been published. Military family members have received minimal attention from clinical outcomes research. Addressing these gaps, this open trial examined IPT for PTSD among veterans, service members, and family members, including a patient subset with comorbid PTSD and depression. METHODS: Fifty U.S. military service members, veterans, and family members (age ≥18 years) were offered 14 sessions of IPT for PTSD. Individuals with psychosis, bipolar disorder, moderate or severe substance use disorders, or high suicide risk were excluded. PTSD and depressive symptoms were assessed at baseline, midtreatment, posttreatment, and 3-month follow-up. RESULTS: Clinician-assessed PTSD (Clinician-Administered PTSD Scale) and depression (Hamilton Depression Rating Scale) symptoms decreased over time in the full sample and the comorbid PTSD/depression subset (p<0.05). Service members, veterans, and family members had similar treatment responses. CONCLUSIONS: Patients receiving IPT showed reductions in PTSD and depressive symptoms. These open trial findings provide preliminary support for the utility of IPT in reducing PTSD symptoms among veterans and family members. This largest IPT trial to date for PTSD in military patients also bolsters the literature on treating military family members.
OBJECTIVE: Military service members and veterans have high rates of posttraumatic stress disorder (PTSD), as do military family members. Exposure-based, cognitive-behavioral approaches have received ample research, but other PTSD therapies require further empirical attention. Interpersonal psychotherapy (IPT) targets affective awareness, life circumstances, and social support. IPT has shown efficacy for civilians with PTSD but awaits rigorous testing among military personnel; only two small military pilot studies and two case reports have been published. Military family members have received minimal attention from clinical outcomes research. Addressing these gaps, this open trial examined IPT for PTSD among veterans, service members, and family members, including a patient subset with comorbid PTSD and depression. METHODS: Fifty U.S. military service members, veterans, and family members (age ≥18 years) were offered 14 sessions of IPT for PTSD. Individuals with psychosis, bipolar disorder, moderate or severe substance use disorders, or high suicide risk were excluded. PTSD and depressive symptoms were assessed at baseline, midtreatment, posttreatment, and 3-month follow-up. RESULTS: Clinician-assessed PTSD (Clinician-Administered PTSD Scale) and depression (Hamilton Depression Rating Scale) symptoms decreased over time in the full sample and the comorbid PTSD/depression subset (p<0.05). Service members, veterans, and family members had similar treatment responses. CONCLUSIONS: Patients receiving IPT showed reductions in PTSD and depressive symptoms. These open trial findings provide preliminary support for the utility of IPT in reducing PTSD symptoms among veterans and family members. This largest IPT trial to date for PTSD in military patients also bolsters the literature on treating military family members.
Authors: Karen M Eaton; Charles W Hoge; Stephen C Messer; Allison A Whitt; Oscar A Cabrera; Dennis McGurk; Anthony Cox; Carl A Castro Journal: Mil Med Date: 2008-11 Impact factor: 1.437
Authors: Ari Lowell; Andrea Lopez-Yianilos; Matthew Ryba; Shay Arnon; Benjamin Suarez-Jimenez; Amit Lazarov; Prudence W Fisher; John C Markowitz; Yuval Neria Journal: Psychiatr Serv Date: 2018-11-30 Impact factor: 3.084
Authors: Edna B Foa; Carmen P McLean; Yinyin Zang; David Rosenfield; Elna Yadin; Jeffrey S Yarvis; Jim Mintz; Stacey Young-McCaughan; Elisa V Borah; Katherine A Dondanville; Brooke A Fina; Brittany N Hall-Clark; Tracey Lichner; Brett T Litz; John Roache; Edward C Wright; Alan L Peterson Journal: JAMA Date: 2018-01-23 Impact factor: 56.272
Authors: Michael O Stewart; Susan D Raffa; Jennifer L Steele; Sarah A Miller; Kathleen F Clougherty; Gregory A Hinrichsen; Bradley E Karlin Journal: J Consult Clin Psychol Date: 2014-07-21
Authors: John C Markowitz; Eva Petkova; Yuval Neria; Page E Van Meter; Yihong Zhao; Elizabeth Hembree; Karina Lovell; Tatyana Biyanova; Randall D Marshall Journal: Am J Psychiatry Date: 2015-02-13 Impact factor: 18.112
Authors: Cecília R Proença; John C Markowitz; Bruno M Coimbra; Hugo Cogo-Moreira; Mariana R Maciel; Andrea F Mello; Marcelo F Mello Journal: Eur J Psychotraumatol Date: 2022-10-14
Authors: Doron Amsalem; Andrea Lopez-Yianilos; Ari Lowell; Alison M Pickover; Shay Arnon; Xi Zhu; Benjamin Suarez-Jimenez; Matt Ryba; Maja Bergman; Sara Such; Hemrie Zalman; Arturo Sanchez-Lacay; Amit Lazarov; John C Markowitz; Yuval Neria Journal: Psychol Trauma Date: 2021-09-16